Valuation: ARYA SCIE

Market Cap 50.04M 44.69M 41.28M 37.41M 69.99M 4.75B 71.15M 497M 197M 2.49B 188M 184M 7.85B P/E 2022
182x
P/E 2023 -50.1x
Enterprise Value 52.2M 46.61M 43.06M 39.02M 73.01M 4.96B 74.21M 518M 205M 2.6B 196M 192M 8.18B EV / Sales 2022
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
14/09/24 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
31/07/24 ARYA Sciences Acquisition Corp IV(NasdaqCM:ARYD) dropped from NASDAQ Composite Index CI
31/07/24 Adagio Medical, Inc. completed the acquisition of ARYA Sciences Acquisition Corp IV from a group of shareholders in a reverse merger transaction. CI
28/06/24 ARYA Sciences Acquisition Corp IV announced that it has received $0.15 million in funding from ARYA Sciences Holdings IV CI
21/05/24 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/03/24 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023 CI
08/02/24 ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV CI
10/11/23 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
27/09/23 ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding CI
11/08/23 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
02/06/23 ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV CI
12/05/23 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
07/04/23 ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022 CI
1 day-7.40%
Current month-98.45%
Current year-98.45%
3 years 0.1
Extreme 0.1009
11.57
5 years 0.1
Extreme 0.1009
11.57
10 years 0.1
Extreme 0.1009
12.38
Manager TitleAgeSince
Corporate Officer/Principal 42 01/01/2021
Director TitleAgeSince
Director/Board Member 55 25/02/2021

Financials

2022 2023
Net sales - -
Net income 1.07M 953K 881K 798K 1.49M 101M 1.52M 10.6M 4.2M 53.09M 4.01M 3.92M 167M -2.13M -1.91M -1.76M -1.59M -2.98M -203M -3.03M -21.18M -8.38M -106M -8.01M -7.84M -335M
Net Debt 0.03 0.03 0.02 0.02 0.04 2.75 0.04 0.29 0.11 1.44 0.11 0.11 4.54 2.15 1.92 1.78 1.61 3.01 204.55 3.06 21.39 8.47 107.17 8.09 7.91 337.89
Projected Income Statement - Annual - ARYA SCIE
Logo ARYA SCIE
ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.
Employees
-
Sector
-
Date Price Change
23/10/26 $0.1026 -7.40%
22/10/26 $0.1108 -3.90%
21/10/26 $0.1153 -4.55%
20/10/26 $0.1208 +0.67%
19/10/26 $0.1200 +21.21%
  1. Stock Market
  2. Stocks
  3. ARYD Stock